AI tool aims to match kids with the right mental health care

NCT ID NCT06834763

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jul 09, 2026 · Last updated Aug 07, 2026 · Updated 2 times

Summary

This study tests a new tool called the Placement Success Predictor (PSP), which uses machine learning to help clinicians decide the best level of care for each child or teen with behavioral health needs. The tool gives a prediction of how likely a youth is to succeed in different placement options, such as outpatient therapy or residential care. Researchers will compare outcomes for youth whose care matches the tool's top recommendations versus those who receive other placements. The goal is to see if using this personalized prediction leads to better mental health improvements.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Placement Success Predictor (PSP) – a machine-learning clinical decision support tool
What this could lead to
If effective, this tool could help match children with the right level of behavioral health care, potentially leading to better and faster improvements in their well-being.
What could go wrong
This is a single study testing a new tool in a real-world setting. The predictions may not always be accurate, and results may vary across different clinics or populations.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

403 people

The number who actually took part.

Started

Feb 2025

Finished

Feb 2026

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Clients at Children's Hope Alliance

Ages

Children (under 18), adults (18 to 64) and older adults (65 and over)

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Completed TOP CS assessment Exclusion Criteria: * None

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Adolescent well-being are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Outcome Referrals, Inc.

    Framingham, Massachusetts, 01701, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.